BioStem Technologies (OTCMKTS:BSEM) Issues Earnings Results

BioStem Technologies (OTCMKTS:BSEM) issued its quarterly earnings results on Monday. The company reported 0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of 0.12 by 0.18, Yahoo Finance reports. The firm had revenue of 74.49 million for the quarter, compared to analyst estimates of 43.99 million.

BioStem Technologies Trading Up 8.4 %

OTCMKTS BSEM traded up 1.05 on Wednesday, hitting 13.55. 180,100 shares of the company were exchanged, compared to its average volume of 26,205. BioStem Technologies has a twelve month low of 1.21 and a twelve month high of 15.50. The company’s 50 day moving average price is 8.97.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.